Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.09
-0.28 (-2.99%)
At close: Sep 15, 2025, 3:59 PM
9.10
0.17%
After-hours: Sep 15, 2025, 05:51 PM EDT
-2.99% (1D)
| Bid | 8.97 |
| Market Cap | 780.35M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -34.93M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -15.94 |
| Forward PE | 4.04 |
| Analyst | Buy |
| Ask | 9.51 |
| Volume | 1,026,784 |
| Avg. Volume (20D) | 1,169,003.6 |
| Open | 9.51 |
| Previous Close | 9.37 |
| Day's Range | 8.85 - 9.56 |
| 52-Week Range | 5.03 - 14.44 |
| Beta | 0.83 |
About AVXL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVXL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVXL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+9.73%
Anavex Life Sciences shares are trading higher. Th...
Unlock content with
Pro Subscription
8 months ago
+8.21%
Anavex Life Sciences shares are trading higher after the company revealed the publication of its peer-reviewed oral blarcamesine Phase IIb/III data in the Journal of Prevention of Alzheimer's Disease.
1 month ago · seekingalpha.com
Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call TranscriptAnavex Life Sciences Corp. (NASDAQ:AVXL ) Q3 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants Christopher U. Missling - President, CEO, Secretary & Director Clint Tomlinso...
